BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
US Department of Justice
QuintilesIMS
McKesson
Harvard Business School
AstraZeneca
Mallinckrodt
US Army
Novartis

Generated: January 23, 2018

DrugPatentWatch Database Preview

BUTALIBITAL, ACETAMINOPHEN AND CAFFEINE Drug Profile

« Back to Dashboard

Which patents cover Butalibital, Acetaminophen And Caffeine, and what generic alternatives are available?

Butalibital, Acetaminophen And Caffeine is a drug marketed by Gilbert Labs and is included in one NDA.

The generic ingredient in BUTALIBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
Summary for BUTALIBITAL, ACETAMINOPHEN AND CAFFEINE
Drug patent expirations by year for BUTALIBITAL, ACETAMINOPHEN AND CAFFEINE

US Patents and Regulatory Information for BUTALIBITAL, ACETAMINOPHEN AND CAFFEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gilbert Labs BUTALIBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine CAPSULE;ORAL 088825-001 Dec 5, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Argus Health
Cipla
Novartis
Citi
Mallinckrodt
US Department of Justice
Fish and Richardson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot